Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach to …

… Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect of chemotherapy
that is frequently experienced by patients receiving treatment for cancer. CIPN is caused by …

… Mechanisms by which chemotherapy-induced neurotoxicity … , including chemotherapy-induced
peripheral neuropathy. A “dying-… to “CIPN, chemotherapy-induced peripheral neuropathy” …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication after
chemotherapy that can damage the sensory, motor, autonomic, or cranial nerves in approximately …

… chronic chemotherapy-induced peripheral neuropathy can … a patient with
chemotherapy-induced peripheral neuropathy. … or worsening of chemotherapy-induced peripheral …

… When peripheral neuropathy occurs due to chemotherapy treatment, it is referred to as
chemotherapy-induced peripheral neuropathy (CIPN). Typically, symptoms are sensory rather …

… Peripheral neuropathies are characterized by nerves … Acquired peripheral neuropathies are
associated with several … the so called Chemotherapy-Induced Peripheral Neuropathy (CIPN)…

… The present review article is the first of two articles focused on chemotherapy-induced
peripheral neuropathy (CIPN), which is one of the most common drug-induced neuropathies and …

Opinion statement Chemotherapy-induced peripheral neuropathy (CIPN) is a common toxicity
associated with treatment with platinum-based agents, taxanes, vinca alkaloids, and other …

… in cancer patients with chemotherapy-induced peripheral neuropathy. The outcomes of
interest included chemotherapy-induced peripheral neuropathy symptoms, physical function (…